Tutorials
Armata Pharmaceuticals Inc logo

Armata Pharmaceuticals Inc

$ 4.25 +0.04 (+0.95%) 11:08 PM EST
P/E:
At Loss
P/B:
2.49
Market Cap:
$ 153.48M
Enterprise V:
$ 144.07M
Volume:
1.50K
Avg Vol (2M):
4.10K
Also Trade In:
Volume:
1.50K
Market Cap $:
153.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
4.10K
Enterprise Value $:
144.07M
PB Ratio:
2.49
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Armata Pharmaceuticals Inc
NAICS : 325414 SIC : 2836
4503 Glencoe Avenue, Marina del Rey, CA, USA, 90292
Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. It is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Further, the company is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Name Current Vs Industry Vs History
Cash-To-Debt 1.21
Equity-to-Asset 0.57
Debt-to-Equity 0.63
Debt-to-EBITDA -1.52
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.1
Distress
Grey
Safe
Beneish M-Score 29.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.7
9-Day RSI 60.47
14-Day RSI 56.74
6-1 Month Momentum % -29.52
12-1 Month Momentum % -4.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.82
Quick Ratio 7.82
Cash Ratio 7.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -127.4

Financials (Next Earnings Date:2022-08-12 Est.)

ARMP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with AMEX:ARMP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.168
EPS (TTM) ($) -1
Beta 0.04
Volatility % 63.17
14-Day RSI 56.74
14-Day ATR ($) 0.2572
20-Day SMA ($) 4.079005
12-1 Month Momentum % -4.39
52-Week Range ($) 2.82 - 6.49
Shares Outstanding (Mil) 36.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Armata Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More